Inflammatory signaling pathways and Cytochrome P450 enzymes

The interaction between inflammatory signaling pathways and Cytochrome P450 (CYP450) enzymes is a critical pharmacological phenomenon where systemic inflammation leads to the suppression of drug-metabolizing enzymes (Aitken et al., 2006, PMID: 16918350). Pro-inflammatory cytokines, such as Interleukin-6 (IL-6) and Tumor Necrosis Factor-alpha (TNF-alpha), trigger intracellular cascades that downregulate the transcription of major CYP isoforms, including CYP3A4, CYP1A2, and CYP2C19, in the liver (Morgan, 2009, PMID: 19433311). This process, often referred to as inflammation-mediated phenoconversion, is primarily driven by the inhibition of nuclear receptors like the Pregnane X Receptor (PXR) and Constitutive Androstane Receptor (CAR) (Zordoky & El-Kadi, 2009, PMID: 19144371). In clinical settings, high levels of inflammation can reduce the clearance of drugs, potentially leading to toxicity for medications with narrow therapeutic indices. Conversely, the administration of anti-inflammatory biologics, such as the IL-6 receptor antagonist tocilizumab, can 'normalize' CYP450 levels, which may result in a rapid increase in drug metabolism and a subsequent loss of therapeutic efficacy for co-administered CYP substrates (Machavaram et al., 2013, PMID: 23533365). Understanding this interplay is vital for managing drug-drug interactions in patients with autoimmune diseases, cancer, or severe infections.

Other names

Cytokine-CYP interactionInflammation-mediated drug metabolism regulationCyp450 downregulation in inflammationInflammation-mediated phenoconversion

Pro-inflammatory cytokines (e.g., IL-6, TNF-alpha, IL-1-beta) activate signaling cascades such as JAK/STAT and NF-kappaB, which suppress the transcriptional expression of Cytochrome P450 enzymes by downregulating or inhibiting nuclear receptors like the Pregnane X Receptor (PXR) and Constitutive Androstane Receptor (CAR) (Aitken et al., 2006, PMID: 16918350). Anti-inflammatory drugs reverse this suppression, restoring metabolic capacity.